Authors
Latest:
From Chaos to Calm: Making Sense of Social MediaMany big pharma companies have been wary of social media. But if you truly want to be customer centric you do need to be in dialogue with your customers - and social media can allow that, writes Will Simpson.
Latest:
Partnering for Holistic SolutionsAs the healthcare landscape evolves, pharmaceutical companies are being driven to embrace new, unique partnerships to go beyond the pill, writes Weng Si Ho.
Latest:
A Brave New World: Optimizing Access in Wake of COVIDThe top changes necessary in planning and designing pharma market access plans, including a revamp of the payer-value equation at pivotal points in the product life cycle.
Latest:
Compliance and Consistency with FDA Required LabelingRuth Trzcienski's reviews FDA's new Procedural Guidance to help manufacturers ensure consistency with the FDA-required labelling.
Latest:
The Trouble with Pharma Partnerships ... And How to Fix ThemA new approach to reviving industry collaborations.
Latest:
Reducing the Risk of NoncomplianceThe key steps to easing rising complexity and cost factors.
Latest:
Reducing the Risk of NoncomplianceThe key steps to easing rising complexity and cost factors.
Latest:
CMED: The ‘Curupira’ of Brazil’s Pharma MarketOutlining one country’s unique price-setting model for novel drugs-and the resulting pre-launch strategies for manufacturers.
Latest:
CMED: The ‘Curupira’ of Brazil’s Pharma MarketOutlining one country’s unique price-setting model for novel drugs-and the resulting pre-launch strategies for manufacturers.
Latest:
CMED: The ‘Curupira’ of Brazil’s Pharma MarketOutlining one country’s unique price-setting model for novel drugs-and the resulting pre-launch strategies for manufacturers.
Latest:
Minimizing Liability with Export Control ComplianceBrooke Ringel and Eric McClafferty outline steps companies should take to ensure compliance with export controls.
Latest:
The Changing Face of Pharma and Biotech Interim ManagementGeoff Newman looks at how pharma and biotech interim management has evolved in the last 20 years.
Latest:
Leveraging Cognitive Search and Search-Based ApplicationsLaurent Fanichet outlines four ways pharma companies can use cognitive search and search-based applications to improve competitiveness.
Latest:
Precision Medicine and Big DataHow integrating next-generation sequencing data can advance efforts in immuno-oncology research.
Latest:
What First Amendment? FDA Remains Unfazed By Off-Label Communication IssuesAn FDA Memo addressing First Amendment legal issues regarding off-label use of medical products falls short of the necessary clarity, write Jamie Kendall and Alexandra Schulz.
Latest:
Addressing eCTDs & New Regulatory Standards for Pharmaceutical Advertising & Promotional MaterialsThomas Christensen outlines some of his lessons learned for first time OPDP submissions, promotional material, and labelling.
Latest:
Securing the Pharma Supply Chain: Current Challenges and Key StepsJeff R. Livingstone outlines the critical steps necessary to ensure an agile, responsive and streamlined supply chain.
Latest:
Improving Customer Engagement: Why Your Data Could Be Letting You DownWhile it is foundational to commercial operations, most European life sciences companies are not getting what they need from their customer data, writes Guillame Roussel.
Latest:
The Doctor is Not In: A Test & Learn Approach to Enhancing the Impact of Non-Personal PromotionIn-market experimentation is the best way to address the challenge of pitching brand leaders on new ways to reach their target population through digital and other non-personal channels, write Scott Beauchamp and Michael Calamari.
Latest:
Price Transparency Regulations are Accelerating Market Disruption. Are You Prepared?As pricing transparency regulations and COVID-19 accelerate market disruption and changes in consumer behavior demand new engagement models, how can your organization prepare for the powerful shift toward more consumer-centric pricing transparency?
Latest:
The Lengthening Arm of PharmacovigilanceExperts debate the practice’s rise up the life sciences agenda.
Latest:
Compliance Regulations in the Trump EraWe know deregulation is coming, although we do not know what it will look like. The one looming question for pharmaceutical and medical device companies is about the future of compliance and regulations.
Latest:
Bracing for Drug Tracing MandatePilot study affirms the value of a standards-based solution for prescription drug traceability-and the need to start now to meet compliance deadlines for the Drug Supply Chain Security Act.
Latest:
Three Ways President Trump's FDA Can Help Cure CancerCuring cancer is not an impossibility anymore. Essential to any effort to achieve this will be the policies coming from President Trump’s administration, writes James Nathanielsz.
Latest:
Preparing For the New ChinaChina's healthcare reforms are generating uncertainty for its domestic pharmaceutical market, writes Jon Zifferblatt.
Latest:
Unlocking value and cost savings in patient services with technology and talentTraci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
Latest:
Why Identity is Imperative for Pharma CompaniesPharma must develop digital identity strategies for creating seamless, safe and compliant customer journeys, writes Jamie Beckland.
